Loading clinical trials...
Loading clinical trials...
Feasibility of Semaglutide Therapy for Weight Loss in Advanced Lung Disease: A Pilot Study
Conditions
Interventions
Semaglutide Pen Injector
Locations
1
United States
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States
Start Date
January 29, 2024
Primary Completion Date
December 28, 2027
Completion Date
December 28, 2027
Last Updated
April 21, 2026
NCT07037459
NCT07351045
NCT07244458
NCT07508241
NCT07395687
NCT07311850
Lead Sponsor
University of Pennsylvania
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions